Filing Details
- Accession Number:
- 0001104659-23-062798
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-19 18:30:35
- Reporting Period:
- 2023-05-18
- Accepted Time:
- 2023-05-19 18:30:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1297184 | Amphastar Pharmaceuticals Inc. | AMPH | Pharmaceutical Preparations (2834) | 330702205 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1866024 | Gayle Deflin | C/O Amphastar Pharmaceuticals, Inc. 11570 6Th Street Rancho Cucamonga CA 91730 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-05-18 | 4,519 | $44.01 | 4,163 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.00 to $44.07, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.